The Discounted Cash Flow (DCF) valuation of Codiak BioSciences, Inc. (CDAK) is (9.05) USD. With the latest stock price at 0.06 USD, the upside of Codiak BioSciences, Inc. based on DCF is -15980.7%.
Based on the latest price of 0.06 USD and our DCF valuation, Codiak BioSciences, Inc. (CDAK) is a sell. selling CDAK stocks now will result in a potential gain of 15980.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 10.1% | 8.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (27.15) - (5.61) | (9.05) |
| Upside | -47724.9% - -9945.9% | -15980.7% |